Arizona State Retirement System’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-31,721
Closed -$108K 2094
2025
Q2
$108K Buy
31,721
+349
+1% +$1.16K ﹤0.01% 2024
2025
Q1
$126K Sell
31,372
-1,069
-3% -$5.54K ﹤0.01% 1993
2024
Q4
$211K Buy
32,441
+311
+1% +$1.85K ﹤0.01% 1936
2024
Q3
$178K Buy
32,130
+1,000
+3% +$5.67K ﹤0.01% 1998
2024
Q2
$174K Buy
31,130
+1,328
+4% +$7.98K ﹤0.01% 1932
2024
Q1
$200K Sell
29,802
-2,599
-8% -$20.6K ﹤0.01% 1931
2023
Q4
$295K Buy
32,401
+7,293
+29% +$45.9K ﹤0.01% 1726
2023
Q3
$139K Buy
25,108
+2,284
+10% +$18.3K ﹤0.01% 2011
2023
Q2
$195K Buy
22,824
+3,287
+17% +$29.5K ﹤0.01% 1964
2023
Q1
$180K Buy
19,537
+543
+3% +$5.84K ﹤0.01% 1967
2022
Q4
$194K Buy
18,994
+744
+4% +$10K ﹤0.01% 1931
2022
Q3
$269K Buy
18,250
+60
+0.3% +$779 ﹤0.01% 1696
2022
Q2
$195K Buy
+18,190
New +$181K ﹤0.01% 1947

Other funds holding CTKB

Arizona State Retirement System's CTKB Position: Q3 2025 in Review

Arizona State Retirement System sold out of Cytek Biosciences (CTKB) in Q3 2025, closing a stake of 31,721 shares — an estimated $108K sold.

Arizona State Retirement System first reported a position in CTKB in Q2 2022 and held it in 13 quarters. The position peaked at $295K in Q4 2023. 153 funds tracked by Wall St. Rank hold CTKB as of Q3 2025.

  • Arizona State Retirement System reported no remaining Cytek Biosciences position as of Q3 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 31,721 Cytek Biosciences shares in Q3 2025, an estimated $108K.
  • Arizona State Retirement System first reported a position in Cytek Biosciences in Q2 2022 and held it in 13 quarters.
  • Arizona State Retirement System's Cytek Biosciences position peaked at $295K in Q4 2023.
  • 153 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2025.

Based on Arizona State Retirement System's 13F filing for Q3 2025, filed 3 Nov 2025.